Membership reinforces commitment to sustainable growth, regional collaboration, and sovereign digital infrastructure in the NordicsREYKJAVÍK, Iceland, June 9, 2026 /PRNewswire/ -- atNorth, the leading...
SINGAPORE, June 9, 2026 /PRNewswire/ -- Today, OpenWay, a global provider of digital payment software, announces its collaboration with Visa, a global leader in digital...
TAIPEI, June 9, 2026 /PRNewswire/ -- ASE Technology Holding Co., Ltd. (NYSE: ASX, TWSE: 3711, "ASEH" or the "Company"), announces its unaudited consolidated net...
GUANGZHOU, China, June 09, 2026 (GLOBE NEWSWIRE) -- EHang Holdings Limited (Nasdaq: EH) (“EHang” or the “Company”), the world’s leading advanced air mobility (“AAM”) technology platform company, today announced its unaudited financial results for the first quarter ended March 31, 2026.
- Achieving Both Cost Reduction and Delivery Reliability with Lead Times Up to 40% Shorter than Conventional Services -TOKYO, June 9, 2026 /PRNewswire/ --...
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Generic Drug Market size & share revenue was valued at approximately USD 491.35 Billion in 2024 and is expected to reach USD 519.11 Billion in 2025 and is expected to reach around USD 926.54 Billion by 2034, at a CAGR of 6.55% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Alkem Laboratories Limited, Teva Pharmaceutical Industries Limited, Cipla Ltd., Dr. Reddy’s Laboratories Ltd., Mylan N.V., Lupin Limited, STADA Arzneimittel AG, Hikma Pharmaceuticals plc, Torrent Pharmaceuticals Ltd., Endo International plc, Aurobindo Pharma Limited, Sawai Pharmaceutical Co. Ltd., Mallinckrodt plc, Amneal Pharmaceuticals Inc and others.
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Generic Drug Market size & share revenue was valued at approximately USD 491.35 Billion in 2024 and is expected to reach USD 519.11 Billion in 2025 and is expected to reach around USD 926.54 Billion by 2034, at a CAGR of 6.55% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Alkem Laboratories Limited, Teva Pharmaceutical Industries Limited, Cipla Ltd., Dr. Reddy’s Laboratories Ltd., Mylan N.V., Lupin Limited, STADA Arzneimittel AG, Hikma Pharmaceuticals plc, Torrent Pharmaceuticals Ltd., Endo International plc, Aurobindo Pharma Limited, Sawai Pharmaceutical Co. Ltd., Mallinckrodt plc, Amneal Pharmaceuticals Inc and others.
SHANGHAI, June 09, 2026 (GLOBE NEWSWIRE) -- NIO Inc. (NYSE: NIO; HKEX: 9866; SGX: NIO) (“NIO” or the “Company”), a pioneer and a leading company in the global smart electric vehicle market, today noted that the U.S. Department of Defense has added the Company to its “Chinese military companies” list (the “CMC List”).
94% of streamers like or love their streaming services;50% of streamers listen to streaming services every day;Streamers are spending 27% more on recorded music,...
SEOUL, South Korea, June 9, 2026 /PRNewswire/ -- Beauty of Joseon has been recognized by global market intelligence company Euromonitor International as the "Global No.1...
JAKARTA, Indonesia, June 9, 2026 /PRNewswire/ -- Malaysia Healthcare Travel Council (MHTC), together with Tourism Malaysia, recorded strong visitor engagement at Malaysia Fair Jakarta 2026,...
BANGKOK, June 9, 2026 /PRNewswire/ -- Hosted by the Trade Development Bureau of the Ministry of Commerce of China and organized by CMEC International Exhibition...